NewGenIvf Group Ltd Files 6-K Report
Ticker: NIVFW · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update, foreign-private-issuer
TL;DR
NewGenIvf Group Ltd (NGIV) filed a 6-K with a press release on Nov 18, 2024. Keep an eye on Exhibit 99.1.
AI Summary
NewGenIvf Group Limited filed a Form 6-K on November 18, 2024, reporting information for the month of November 2024. The filing includes a press release as Exhibit 99.1. The company's principal executive offices are located in Bangkok, Thailand, and its mail address is in Hong Kong. Wing Fung Alfred Siu signed the report on behalf of the company.
Why It Matters
This filing provides an update on the company's activities and regulatory disclosures, which is important for investors to stay informed about the company's status and any new information released.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- NewGenIvf Group Limited (company) — Filer of the 6-K report
- Wing Fung Alfred Siu (person) — Signed the report on behalf of the company
- November 18, 2024 (date) — Filing date of the 6-K report
- ASPAC I Mini Acquisition Corp. (company) — Former company name
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What is included in this specific 6-K filing?
This filing includes Exhibit 99.1, which is a press release, and the signature of Wing Fung Alfred Siu on behalf of NewGenIvf Group Limited.
Where are NewGenIvf Group Limited's principal executive offices located?
The company's principal executive offices are located at 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke), Khlong Toei Nuea Sub-district, Watthana District, Bangkok 10110, Thailand.
When did NewGenIvf Group Limited change its name?
The company changed its name from ASPAC I Mini Acquisition Corp. on June 14, 2023.
What is the SEC file number for NewGenIvf Group Limited?
The SEC file number for NewGenIvf Group Limited is 001-42004.
Filing Stats: 159 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-11-18 07:43:25
Filing Documents
- ea0221609-6k_newgen.htm (6-K) — 13KB
- ea022160901ex99-1_newgen.htm (EX-99.1) — 9KB
- 0001213900-24-099350.txt ( ) — 23KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-42004 NEWGENIVF GROUP LIMITED 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press release 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 18, 2024 NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director 2